Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Rajwinder Kaur is Assistant Dean of Pharm D (Academics) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. She has extensive experience in teaching and research and has held academic and research positions, including appointment as a DST Women Scientist at Panjab University, Chandigarh. Her research focuses on computational drug design, fused heterocyclic compounds, nanomedicine, and the application of artificial intelligence in pharmaceutical research, with particular interests in inflammation, asthma, and neurological disorders. Dr. Kaur has contributed extensively to the scientific literature through scholarly publications, book chapters, and editorial work. She is actively involved in academic and research initiatives that promote innovation in pharmaceutical sciences and interdisciplinary drug discovery. She is a Senior Member of the Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES) and a Life Member of the Indian Pharmacy Graduate Association (IPGA). Dr. Thakur Gurjeet Singh is a pharmacology researcher with extensive graduate training in clinical and preclinical drug development. His work focuses on the neuroprotective mechanisms of pharmacological preconditioning in neurodegenerative disorders such as Alzheimer’s disease, Parkinsonism, stroke, epilepsy, and dementia. He has investigated key protective pathways involving adenosine, opioids, CGRP, calcium signaling, protein kinase-C, heat shock proteins, and MAP kinase. His research also explores novel therapeutic pathways using agents such as morphine and capsaicin, with additional expertise in mechanistic studies of substance dependence, including nicotine, alcohol, and morphine addiction. Dr. Singh’s core competencies include animal model development and validation, anesthetic and preconditioning techniques, histopathological analysis, and behavioral data evaluation. His broader interests include ALS, stem cell therapy, and movement disorders such as tardive dyskinesia.Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences. Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at the Centre for Research Impact & Outcome (CRIO), Chitkara University, and Sharda University. His research portfolio encompasses over 200 peer-reviewed articles and scholarly reviews, along with an edited volume published by Springer, reflecting sustained contributions to biomedical research and translational science. According to Scopus metrics, Dr. Jha’s publications have garnered more than 10,000 citations, with an H-index exceeding 50, underscoring the broad impact and visibility of his work within the global scientific community. He is an elected Member of the Royal Society of Biology (MRSB), London, and has been recognized among the World’s Top 2% Scientists in rankings compiled by Elsevier in collaboration with Stanford University. Dr. Jha actively contributes to scientific publishing and peer review as an associate editor for the Journal of Alzheimer’s Disease (IOS Press) and IET Nanobiotechnology (Wiley) and serves on the editorial boards of several international journals, including Scientific Reports. His research is centered on elucidating the molecular and cellular mechanisms underlying complex diseases such as neurodegenerative disorders, cancer, and cardiovascular pathologies. His work particularly emphasizes the modulation of key signaling pathways and explores the therapeutic potential of natural products, phytochemicals, and synthetic small molecules in disease intervention.

Select Guide Rating

• 1. Introduction to Brain Tumors2. Molecular Pathogenesis of Brain Tumors3. Pharmacokinetics and Pharmacodynamics in Brain Tumor Treatment4. Conventional Chemotherapeutic Approaches for Brain Tumor Treatment5. Targeted Molecular Therapies for Brain Tumor6. Immunotherapy and Brain Tumors7. Epigenetic Therapies for Brain Tumor8. Nanotechnology and Drug Delivery Systems for Brain Tumor9. Stem Cells in Brain Tumor Therapy10. Harnessing Oxidative Stress: Novel Therapeutics in Pediatric Brain Cancer11. Advanced Imaging Techniques in Brain Tumor Diagnosis and Surgery12. Combination Therapies for Brain Therapy: Synergistic Approaches13. Decoding MGMT: Biochemistry, Drug Resistance, and Diagnostic Innovations14. Molecular Mechanisms of Drug Resistance in Brain Therapy15. Personalized Medicine in Brain Tumors16. Innovations and Obstacles in Pediatric Brain Cancer Therapy17. Clinical Trials and Regulatory Aspects for Brain Tumor Treatment18. Future Directions in Brain Tumor Therapy19. Case Studies and Real-World Applications

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Rajwinder Kaur is Assistant Dean of Pharm D (Academics) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. She has extensive experience in teaching and research and has held academic and research positions, including appointment as a DST Women Scientist at Panjab University, Chandigarh. Her research focuses on computational drug design, fused heterocyclic compounds, nanomedicine, and the application of artificial intelligence in pharmaceutical research, with particular interests in inflammation, asthma, and neurological disorders. Dr. Kaur has contributed extensively to the scientific literature through scholarly publications, book chapters, and editorial work. She is actively involved in academic and research initiatives that promote innovation in pharmaceutical sciences and interdisciplinary drug discovery. She is a Senior Member of the Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES) and a Life Member of the Indian Pharmacy Graduate Association (IPGA). Dr. Thakur Gurjeet Singh is a pharmacology researcher with extensive graduate training in clinical and preclinical drug development. His work focuses on the neuroprotective mechanisms of pharmacological preconditioning in neurodegenerative disorders such as Alzheimer’s disease, Parkinsonism, stroke, epilepsy, and dementia. He has investigated key protective pathways involving adenosine, opioids, CGRP, calcium signaling, protein kinase-C, heat shock proteins, and MAP kinase. His research also explores novel therapeutic pathways using agents such as morphine and capsaicin, with additional expertise in mechanistic studies of substance dependence, including nicotine, alcohol, and morphine addiction. Dr. Singh’s core competencies include animal model development and validation, anesthetic and preconditioning techniques, histopathological analysis, and behavioral data evaluation. His broader interests include ALS, stem cell therapy, and movement disorders such as tardive dyskinesia.Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences. Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at the Centre for Research Impact & Outcome (CRIO), Chitkara University, and Sharda University. His research portfolio encompasses over 200 peer-reviewed articles and scholarly reviews, along with an edited volume published by Springer, reflecting sustained contributions to biomedical research and translational science. According to Scopus metrics, Dr. Jha’s publications have garnered more than 10,000 citations, with an H-index exceeding 50, underscoring the broad impact and visibility of his work within the global scientific community. He is an elected Member of the Royal Society of Biology (MRSB), London, and has been recognized among the World’s Top 2% Scientists in rankings compiled by Elsevier in collaboration with Stanford University. Dr. Jha actively contributes to scientific publishing and peer review as an associate editor for the Journal of Alzheimer’s Disease (IOS Press) and IET Nanobiotechnology (Wiley) and serves on the editorial boards of several international journals, including Scientific Reports. His research is centered on elucidating the molecular and cellular mechanisms underlying complex diseases such as neurodegenerative disorders, cancer, and cardiovascular pathologies. His work particularly emphasizes the modulation of key signaling pathways and explores the therapeutic potential of natural products, phytochemicals, and synthetic small molecules in disease intervention.

Select Guide Rating

• 1. Introduction to Brain Tumors2. Molecular Pathogenesis of Brain Tumors3. Pharmacokinetics and Pharmacodynamics in Brain Tumor Treatment4. Conventional Chemotherapeutic Approaches for Brain Tumor Treatment5. Targeted Molecular Therapies for Brain Tumor6. Immunotherapy and Brain Tumors7. Epigenetic Therapies for Brain Tumor8. Nanotechnology and Drug Delivery Systems for Brain Tumor9. Stem Cells in Brain Tumor Therapy10. Harnessing Oxidative Stress: Novel Therapeutics in Pediatric Brain Cancer11. Advanced Imaging Techniques in Brain Tumor Diagnosis and Surgery12. Combination Therapies for Brain Therapy: Synergistic Approaches13. Decoding MGMT: Biochemistry, Drug Resistance, and Diagnostic Innovations14. Molecular Mechanisms of Drug Resistance in Brain Therapy15. Personalized Medicine in Brain Tumors16. Innovations and Obstacles in Pediatric Brain Cancer Therapy17. Clinical Trials and Regulatory Aspects for Brain Tumor Treatment18. Future Directions in Brain Tumor Therapy19. Case Studies and Real-World Applications

Arun Kumar Singh is an Assistant Professor in the Department of Pharmacy at University School of Pharmaceutical Sciences, Rayat Bahra University V.P.O. Sahauran, India. He completed his M.Pharm in Pharmaceutics from Galgotias University, Greater Noida. His research interests include nano-formulation, blockchain, IoT, machine learning, artificial intelligence, big data analytics, cancer biology, and neuroscience. He has contributed to academic books and book chapters and has published review articles in the areas of pharmaceutical sciences and healthcare technology. His work focuses on interdisciplinary approaches integrating pharmaceutical research with emerging digital and computational technologies. Rajwinder Kaur is Assistant Dean of Pharm D (Academics) at Chitkara College of Pharmacy, Chitkara University, Punjab, India. She has extensive experience in teaching and research and has held academic and research positions, including appointment as a DST Women Scientist at Panjab University, Chandigarh. Her research focuses on computational drug design, fused heterocyclic compounds, nanomedicine, and the application of artificial intelligence in pharmaceutical research, with particular interests in inflammation, asthma, and neurological disorders. Dr. Kaur has contributed extensively to the scientific literature through scholarly publications, book chapters, and editorial work. She is actively involved in academic and research initiatives that promote innovation in pharmaceutical sciences and interdisciplinary drug discovery. She is a Senior Member of the Hong Kong Chemical, Biological & Environmental Engineering Society (HKCBEES) and a Life Member of the Indian Pharmacy Graduate Association (IPGA). Dr. Thakur Gurjeet Singh is a pharmacology researcher with extensive graduate training in clinical and preclinical drug development. His work focuses on the neuroprotective mechanisms of pharmacological preconditioning in neurodegenerative disorders such as Alzheimer’s disease, Parkinsonism, stroke, epilepsy, and dementia. He has investigated key protective pathways involving adenosine, opioids, CGRP, calcium signaling, protein kinase-C, heat shock proteins, and MAP kinase. His research also explores novel therapeutic pathways using agents such as morphine and capsaicin, with additional expertise in mechanistic studies of substance dependence, including nicotine, alcohol, and morphine addiction. Dr. Singh’s core competencies include animal model development and validation, anesthetic and preconditioning techniques, histopathological analysis, and behavioral data evaluation. His broader interests include ALS, stem cell therapy, and movement disorders such as tardive dyskinesia.Ashutosh Pareek is Professor at Banasthali Vidyapith, India, with expertise in neuropharmacology and advanced drug delivery systems. His research focuses on therapeutic strategies for neurodegenerative disorders, cancer, autoimmune diseases, and related health conditions, with particular interest in the development of innovative drug delivery approaches for bioactive and immunomodulatory compounds. Dr. Pareek leads research initiatives in these areas and collaborates with national and international funding agencies on projects that advance pharmaceutical science and translational research. He has contributed extensively to the scientific literature through scholarly publications, books, patents, and research mentorship. In addition, he serves on editorial and peer-review activities for international journals in pharmacology and oncology, supporting the dissemination and evaluation of research across the biomedical sciences. Dr. Niraj Kumar Jha is an Assistant Professor of Biotechnology at Galgotias University, India, with prior research affiliations at the Centre for Research Impact & Outcome (CRIO), Chitkara University, and Sharda University. His research portfolio encompasses over 200 peer-reviewed articles and scholarly reviews, along with an edited volume published by Springer, reflecting sustained contributions to biomedical research and translational science. According to Scopus metrics, Dr. Jha’s publications have garnered more than 10,000 citations, with an H-index exceeding 50, underscoring the broad impact and visibility of his work within the global scientific community. He is an elected Member of the Royal Society of Biology (MRSB), London, and has been recognized among the World’s Top 2% Scientists in rankings compiled by Elsevier in collaboration with Stanford University. Dr. Jha actively contributes to scientific publishing and peer review as an associate editor for the Journal of Alzheimer’s Disease (IOS Press) and IET Nanobiotechnology (Wiley) and serves on the editorial boards of several international journals, including Scientific Reports. His research is centered on elucidating the molecular and cellular mechanisms underlying complex diseases such as neurodegenerative disorders, cancer, and cardiovascular pathologies. His work particularly emphasizes the modulation of key signaling pathways and explores the therapeutic potential of natural products, phytochemicals, and synthetic small molecules in disease intervention.

Select Guide Rating

• 1. Introduction to Brain Tumors2. Molecular Pathogenesis of Brain Tumors3. Pharmacokinetics and Pharmacodynamics in Brain Tumor Treatment4. Conventional Chemotherapeutic Approaches for Brain Tumor Treatment5. Targeted Molecular Therapies for Brain Tumor6. Immunotherapy and Brain Tumors7. Epigenetic Therapies for Brain Tumor8. Nanotechnology and Drug Delivery Systems for Brain Tumor9. Stem Cells in Brain Tumor Therapy10. Harnessing Oxidative Stress: Novel Therapeutics in Pediatric Brain Cancer11. Advanced Imaging Techniques in Brain Tumor Diagnosis and Surgery12. Combination Therapies for Brain Therapy: Synergistic Approaches13. Decoding MGMT: Biochemistry, Drug Resistance, and Diagnostic Innovations14. Molecular Mechanisms of Drug Resistance in Brain Therapy15. Personalized Medicine in Brain Tumors16. Innovations and Obstacles in Pediatric Brain Cancer Therapy17. Clinical Trials and Regulatory Aspects for Brain Tumor Treatment18. Future Directions in Brain Tumor Therapy19. Case Studies and Real-World Applications